Craig Hallum upgraded shares of QT Imaging (NASDAQ:QTI – Free Report) to a strong-buy rating in a research report report published on Monday morning,Zacks reports.
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of QT Imaging in a research report on Friday, July 10th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, QT Imaging presently has a consensus rating of “Moderate Buy” and an average target price of $8.00.
Check Out Our Latest Analysis on QTI
QT Imaging Stock Performance
QT Imaging (NASDAQ:QTI – Get Free Report) last issued its quarterly earnings results on Wednesday, August 12th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.53). QT Imaging had a negative net margin of 77.25% and a negative return on equity of 1,202.69%. The business had revenue of $7.44 million during the quarter, compared to analyst estimates of $7.60 million. Research analysts forecast that QT Imaging will post -1.11 EPS for the current fiscal year.
Institutional Trading of QT Imaging
Several hedge funds have recently added to or reduced their stakes in QTI. Stonepine Capital Management LLC bought a new position in QT Imaging during the 2nd quarter worth $407,000. BlackRock Inc. boosted its holdings in shares of QT Imaging by 116.5% in the 2nd quarter. BlackRock Inc. now owns 61,353 shares of the company’s stock valued at $250,000 after purchasing an additional 33,009 shares in the last quarter. Finally, Polar Asset Management Partners Inc. acquired a new stake in shares of QT Imaging in the 2nd quarter valued at $210,000. 24.19% of the stock is owned by institutional investors and hedge funds.
QT Imaging Company Profile
QT Imaging Holdings, Inc (NASDAQ:QTI) is a medical technology company focused on developing and commercializing advanced breast-imaging systems. Its technology is designed to provide three-dimensional images of the breast without ionizing radiation or breast compression, supporting breast health assessment and potentially improving patient comfort.
The company’s primary product is the QTscan system, an automated breast-imaging platform that uses transmission ultrasound technology to create detailed images of breast tissue.
Featured Articles
- Five stocks we like better than QT Imaging
- NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run
- A Manufacturing Surprise Could Be a Big Win for These 2 Companies
- What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions
- 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
